JP2024517855A5 - - Google Patents
Info
- Publication number
- JP2024517855A5 JP2024517855A5 JP2023568204A JP2023568204A JP2024517855A5 JP 2024517855 A5 JP2024517855 A5 JP 2024517855A5 JP 2023568204 A JP2023568204 A JP 2023568204A JP 2023568204 A JP2023568204 A JP 2023568204A JP 2024517855 A5 JP2024517855 A5 JP 2024517855A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion polypeptide
- amino acid
- metal hydroxide
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184620P | 2021-05-05 | 2021-05-05 | |
| US63/184,620 | 2021-05-05 | ||
| PCT/US2022/027617 WO2022235755A2 (en) | 2021-05-05 | 2022-05-04 | Fusion polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517855A JP2024517855A (ja) | 2024-04-23 |
| JP2024517855A5 true JP2024517855A5 (https=) | 2025-05-15 |
Family
ID=82020825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568204A Pending JP2024517855A (ja) | 2021-05-05 | 2022-05-04 | 融合ポリペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US12454695B2 (https=) |
| EP (1) | EP4334337A2 (https=) |
| JP (1) | JP2024517855A (https=) |
| KR (1) | KR20240028341A (https=) |
| AU (1) | AU2022269602A1 (https=) |
| CA (1) | CA3217079A1 (https=) |
| IL (1) | IL308240A (https=) |
| WO (1) | WO2022235755A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4334337A2 (en) | 2021-05-05 | 2024-03-13 | Ankyra Therapeutics, Inc. | Fusion polypeptides |
| CA3234552A1 (en) | 2021-10-20 | 2023-04-27 | Synthekine, Inc. | Heterodimeric fc cytokines and uses thereof |
| JP2025540624A (ja) * | 2022-11-09 | 2025-12-16 | アンキラ セラピューティクス，インコーポレイテッド | 融合ポリペプチドを作製する方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019346335B2 (en) * | 2018-09-28 | 2024-07-25 | Massachusetts Institute Of Technology | Collagen-localized immunomodulatory molecules and methods thereof |
| WO2020263399A1 (en) | 2019-06-26 | 2020-12-30 | Massachusetts Institute Of Technology | Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof |
| EP4334337A2 (en) | 2021-05-05 | 2024-03-13 | Ankyra Therapeutics, Inc. | Fusion polypeptides |
-
2022
- 2022-05-04 EP EP22730331.0A patent/EP4334337A2/en active Pending
- 2022-05-04 KR KR1020237041893A patent/KR20240028341A/ko active Pending
- 2022-05-04 IL IL308240A patent/IL308240A/en unknown
- 2022-05-04 CA CA3217079A patent/CA3217079A1/en active Pending
- 2022-05-04 AU AU2022269602A patent/AU2022269602A1/en active Pending
- 2022-05-04 US US17/736,431 patent/US12454695B2/en active Active
- 2022-05-04 JP JP2023568204A patent/JP2024517855A/ja active Pending
- 2022-05-04 WO PCT/US2022/027617 patent/WO2022235755A2/en not_active Ceased
-
2025
- 2025-06-26 US US19/251,378 patent/US20250327085A1/en active Pending
- 2025-10-08 US US19/352,767 patent/US20260035706A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024517855A5 (https=) | ||
| JP2024071384A (ja) | 核酸ワクチン | |
| JP4303595B2 (ja) | アニオン性置換基を有する物質を捕捉可能な亜鉛錯体 | |
| Walton et al. | Branched-chain sugar nucleosides. V. Synthesis and antiviral properties of several branched-chain sugar nucleosides | |
| US20160354482A1 (en) | Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses | |
| JP2021527042A (ja) | 腫瘍微小環境活性化薬物・結合剤コンジュゲート、及びそれに関連する使用 | |
| JPH07505283A (ja) | Ｄｎａトランスポーター系および使用方法 | |
| JP2002513795A (ja) | モノマー、オリゴマーおよびポリマーのクネベナーゲル縮合生成物 | |
| Zimmermann et al. | RNA-protein interactions in the ribosome: II. Binding of ribosomal proteins to isolated fragments of the 16 S RNA | |
| CN109414495B (zh) | 具有定制响应性光学成像的ebv相关肿瘤的治疗抑制剂 | |
| JP2018531287A5 (https=) | ||
| CA3212822A1 (en) | Compound or salt thereof, and antibody obtained by using the same | |
| CN112409450B (zh) | TIGIT-IgV的亲和剂及其应用 | |
| CN116802207A (zh) | Il10rb结合分子及使用方法 | |
| JP2022537052A (ja) | 操作された腫瘍選択的タンパク質発現 | |
| JP2022528053A5 (https=) | ||
| CN111138521A (zh) | 源自于afp抗原的短肽 | |
| ATE266731T1 (de) | Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung | |
| RU2017135552A (ru) | Глутамат оксалоацетат трансаминаза 1 (got1), препараты и способы их получения и применения | |
| DE102005060920A1 (de) | Peptide für die Wechselwirkung mit alpha-helikalen Coiled-Coil-Strukturen und/oder Coiled-Coil-Sequenzen, davon abgeleitete Mittel und ihre Verwendung | |
| CN109157656B (zh) | 一种双靶标肿瘤疫苗及其制备方法和应用 | |
| TW201809013A (zh) | 用於藥物遞送之抗體融合蛋白 | |
| JP2024516392A5 (https=) | ||
| DE3685636T2 (de) | Lysozymbetreffende peptide. | |
| CN108250289B (zh) | 源自于mage b6的肿瘤抗原短肽 |